Make $250.00 - RLS is a disorder of the nervous system affecting movement of the legs, usually interfering with sleep. If you are suffering from this disorder, you may wish to consider a clinical research study of a   more »

"We think this will be a huge boost for the science," said acting NIH director Raynard Kington. "This was the right policy for the agency at this point in time." The limit will disappoint some researchers who wanted to use a broader variety of cells. But it still means that perhaps   more »

It is a time of exciting evolution and expansion in MS research, and there are many potentially life-changing MS therapies that are making their way through the medical pipeline. The Rocky Mountain MS Center, along with other organizations, is committed   more »

Given the multitude of published reports on the effects of thermal manipulation of the hands or feet on core temperatures and performance and on the effects of thermal manipulations on performance and symptom exacerbation in individuals with MS,   more »

When the individual subject’s mean data were analyzed according to subject and treatment, treatment extended exercise duration by an average of 35% (42.8 ± 16.4 with cooling compared to 31.7 ± 9.8 minutes without cooling, mean ± standard deviation, n   more »

Researchers at Aurora St. Luke's Medical Center have developed a technique that counteracts an unusual, but serious, side effect from natalizumab (Tysabri®), a drug that   more »

The heat extraction device consisted of a rigid chamber into which one hand was inserted through an elastic sleeve that formed a flexible airtight seal around the wrist. The rigid chamber was connected to a pressure sensor and a vacuum pump. The vacuum pump created a slight sub-atmospheric pressure   more »

BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAESTRO-03 trial of Dirucotide in   more »

Many individuals afflicted with multiple sclerosis (MS) have experienced a transient worsening of symptoms when body temperature increases due to ambient conditions or physical activity. Resulting symptom exacerbations can limit performance. Researches hypothesized that extraction of heat from the body through   more »

The purpose of this study is to determine the effectiveness of a new treatment for multiple sclerosis (MS), a serious disease in which the immune system attacks the brain and spinal cord. MS can be progressive and severe and lead to significant disability. The study   more »

Women who have multiple sclerosis may reduce their risk of relapses after pregnancy if they breastfeed their babies, according to a study released today that will be presented at the American Academy of Neurology’s   more »

People who start smoking before age 17 may increase their risk for developing multiple sclerosis (MS), according to a study released today that will be presented at the American Academy   more »

Biovista Inc. today announced that BVA-101, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-101, an existing drug that Biovista repositioned   more »

Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event. Background There is no specific serum-based biomarker for   more »